Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Hematology
0253-2727
2008 Issue 1
zhong hua xue ye xue za zhi gao yue
..............page:插页4
fu hong xi bao ti bing er li
liu qing chi ; wu wei hai ; ma chuan bao ; zhang hui min ; li gang rong ; wang rong xiao
..............page:70
er tong mu xi bao xing nk xi bao lin ba liu yi li
li qiang ; guo xia
..............page:51
ban you jak2 v617f tu bian de man xing zhong xing li xi bao bai xue bing yi li
guo hui mei ; pan ; zhang xue jun ; wang fu xu ; guo xiao ling ; dong zuo ren
..............page:38
xue ye bing he bing jie he san li bao gao fu wen xian fu xi
wang wei ; chen hui shu ; yang chong li
..............page:65-66
ka bo fen jing zhi liao qin xi xing zhen jun gan ran 27 li lin chuang yan jiu
zhu dan ; meng fan yi ; huang fen ; zhang zuo ; sun qi zuo ; ou yang zhao ; xu bing ; liu xiao li ; feng ru
..............page:63-64
Efficacy and safety of imatinib in treatment of 151 chromc myeloid leukemia patients
ZHOU Li;WANG Ai-hua;WANG Li;YOU Jian-hua;LI Jun-min;SHEN Zhi-xiang
..............page:13-17
HAA regimen as induction chemotherapy for newly diagnosed acute myelogenous leukemia
LIU Hui;QIAN Wen-bin;MAI Wen-yuan;MENG Hai-tao;TONG Hong-yan;TONG Yin;MAO Li-ping;HUANG Jian;WANG Lei;JIANG Dao-zi;JIN Jie
..............page:9-12
Studying of clinical and laboratory features of chronic eosinophilic leukemias/hypereosinophilic syndrome
ZHANG Yue;YU Ming-hua;XU Shi-cai;YANG Lin;YU Yang;HAO Yu-shu;XIAO Zhi-jian
..............page:3-8
gao qian yi lv zu dan bai -1 you dao u937 xi bao fen mi bai xi bao jie su -1 de shi yan yan jiu
kang zuo ; tang dao lin ; cao li zhi ; yu yan ; zhang guo yuan
..............page:56-57
fu da la bin zhi liao man xing lin ba xi bao bai xue bing 41 li lin chuang guan cha
xu wei ; li jian yong ; wu han xin ; qian si xuan ; lu hua ; chou hong xia ; cao xiang shan ; li li ; yu hui ; sheng rui lan
..............page:54-56
hypercvad fang an zhi liao cheng ren gao wei ji xing lin ba xi bao bai xue bing de liao xiao guan cha
li wei yang ; sun ai ning ; wu de pei ; ji cheng fu ; fu ( wang zheng )( wang zheng ); jin zheng ming ; he guang sheng ; zhou hai xia ; yan ling zhi
..............page:52-53
Study on the pathogenesis of blood cytopenia in patients with systemic lupus erythematosus
FU Rong;Uehara Toukiko;GONG Lu;SHAO Zong-hong
..............page:48-51
Relationship between the long type PML-RARα and the prognosis of patients with acute promyelocytic leukemia
TAN Yan-hong;WANG Hong-wei;ZHANG Zhi-ping;LIU Wei;GUO Hui-min;ZHU Lei;ZHANG Li
..............page:44-47
The cytotoxicity of CIK/NK cells stimulated by K562-DC fusion vaccines in NOD/SCID mice model for human erythroleukemia
LI Yang;HUANG Shao-liang;ZHANG Xu-chao;FANG Jian-pei;WU Yan-feng;WEI Jing;HUANG Wen-ge;ZHOU Dun-hua;HUANG Ke;LIN Yong-chao
..............page:39-43
Targeted blockage of RNA binding protein E2 by decoy RNA induces the granulocytic differentiation of K562 cells
CHEN Xin-min;FENG Wen-li;XU Song-xiao;ZENG Jian-ming;ZHAO Shi-qiao;LUO Hong-wei;BAI Wei-jun;WANG Xiao-zhong;HUANG Zong-gan
..............page:34-38
Comparison of polyethylene glycol conjugated asparaginase and L-asparaginase for treatment of childhood acute lymphoblastic leukemia
The Cooperation Group of Phase Ⅱ Clinical Trial of PEG-Asp
..............page:29-33
The immunophenotypic analysis of CD7+ and(or)CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection
CAO Hui;WANG Ya-zhe;WU Hong-hong;CHANG Yan;HAO Le;CHEN Shan-shan;HUANG Xiao-jun;LU Dao-pei;LIU Yan-rong
..............page:23-28
Analysis of long-term treatment outcome and related factors in 95 chronic myeloid leukemia patients treated with imatinib
WANG Guo-rong;ZHAO Yao-zhong;QIAN Lin-sheng;ZOU De-hui;LI Rui;MI Ying-chang;WANG Jian-xiang;QIU Lu-gui
..............page:18-22